Financials
Income statement
Fiscal date | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
---|---|---|---|---|
Total reported revenue | 180.8B | 177.2B | 177.6B | 166.1B |
Cost of revenue | 137.3B | 129.5B | 131.6B | 123.7B |
Gross profit | 43.6B | 47.7B | 46.1B | 42.4B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | — | — | — | — |
Operating income | 6.6B | 13.2B | 12.4B | 10.3B |
Non operating interest income | ||||
Income | 405M | 496M | 266M | 276M |
Expense | 2.3B | 1.7B | 1.5B | 1.4B |
Other income expense | — | — | — | — |
Pretax income | 4.0B | 11.4B | 11.5B | 9.8B |
Tax provision | 1.0B | 3.4B | 1.5B | 3.2B |
Net income | 2.9B | 8.0B | 10.0B | 6.6B |
Basic EPS | — | — | — | 62.0 |
Diluted EPS | — | — | — | 61.8 |
Basic average shares | — | — | — | 106.6M |
Diluted average shares | — | — | — | 107.0M |
EBITDA | 17.7B | 22.2B | 22.5B | 19.2B |
Net income from continuing op. | 4.0B | 11.4B | 11.5B | 9.8B |
Minority interests | 2M | -7M | -14M | -10M |
Preferred stock dividends | 0 | 0 | 0 | 0 |